News and Events
| Thursday, 27 March 2008 00:00 |
|
"The CRO industry in Europe is predicted to experience double-digit growth over the next five years due to both growth in drug development and the increasing use of outsourcing by pharmaceutical, biotechnology and medical device companies. There are several hundred Contract Research Organisations in Europe. This report profiles the Top 100 of them. These companies offer their sponsors a full range of outsourced services including: product development, formulation and manufacturing; clinical trial management (preclinical through phase IV); clinical, medical and safety monitoring; preclinical, toxicology, and clinical laboratory services for processing trial samples; data management, biostatistics and medical writing services; regulatory affairs support; and many other complementary services. Outsourcing offers a number of advantages including access to medical and clinical knowledge in specific therapeutic areas and knowledge of regulatory affairs in a particular country of interest." Cromos Pharma profiled in The Top 20 Contract Research Organizations in Europe in Research and Markets. |
News and messages from CEO,
Dr Vladimir Bogin
12.04.2012 |
Cromos™ Pharma has announced today an addition of a new service - registration of medicinal products in the Russian Federation. [...] |
19.03.2012 |
Meet us at ASCO Annual Meeting in Chicago, IL, USA on 1-5 June 2012. [...] |
12.01.2012 |
Cromos Pharma has participated in the conference on clinical trials in emerging markets in Tel-Aviv, Israel on 11 January 2012. [...] |
05.01.2012 |
Meet Cromos Pharma's CEO, Dr. Vladimir Bogin at the 30th JP Morgan Healthcare Conference in San Francisco, CA on 9-12 January 2012. [...] |
14.12.2011 |
Cromos Pharma published a white paper with review of Russian clinical trials market in 2011. [...] |
